Stocks · News reference
Congressional Inquiry into Centene's Role in Health Coverage Terminations
U.S. Senators have sent a letter to Centene and other major insurers demanding information regarding their cooperation with the administration in terminating health coverage for 760,000 enrollees.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Canada Nickel Company Inc. Extends Loan Facility with Auramet International
Canada Nickel Company Inc. has extended the maturity date of its loan facility with Auramet International, Inc. to February 9, 2027, while reducing the outstanding principal balance.
Sunflower State Health Plan Earns 4-Star NCQA Rating
Sunflower State Health Plan, a subsidiary of Centene Corporation, received a 4 out of 5-star rating in the 2026 NCQA Medicaid Health Plan Ratings.
US Department of Justice Intervenes in Whistleblower Lawsuit Against Centene Corporation
The U.S. government has intervened in a False Claims Act lawsuit alleging that Centene Corporation engaged in fraudulent Medicare Advantage enrollment practices.
Goldman Sachs Adjusts Centene Price Target to $62 From $56
Goldman Sachs has revised its price target for Centene Corporation, increasing it from $56 to $62.
Deutsche Bank Adjusts Centene Price Target to $87 From $85
Deutsche Bank has raised its price target for Centene Corporation from $85 to $87 while maintaining a Buy rating.